Good morning everyone, and welcome to Monday, September 30, 1841 – an important date in the history of office stationery.
That’s because on this day in 1841 that a bloke called Samuel Slocum was granted a patent for what we now know as “the stapler” – a feat I am assuming he managed by submitting all of the requisite patent application paperwork in triplicate, without using a single short piece of string to bind them all together.
Luckily for you, you won’t actually have to completely destory the global market for short pieces of string in order to get your hands on good pre-market info today.
That’s because – as always – we’ve worked super-hard to gather together lots of fiddly little things below, so you don’t need to go ferreting all over the internet for your ASX info this morning.
COMMODITY/FOREX/CRYPTO MARKET PRICES
Gold: US$2,6758/.40 (-0.53%)
Silver: US$31.82 (-1.11%)
Nickel (3mth): US$17,041/t (+1.77%)
Copper (3mth): US$9,846/t (-0.99%)
Zinc: US$3,080/t (-0.61%)
Oil (WTI): US$68.10 (+0.75%)
Oil (Brent): US$71.09 (+102.85/t (+4.40%)
AUD/USD: 0.6904 (+0.45%)
Bitcoin: US$65,617.30 (-0.36%)
WHAT GOT YOU TALKING
Which ASX energy juniors stand to win from WA’s new domestic gas rules? Read the latest iteration of Got Gas to find out…
GOT GAS: Which ASX energy juniors stand to win from WA’s new domestic gas rules? https://t.co/5HrpH9krfY
— Stockhead (@StockheadAU) September 27, 2024
YESTERDAY’S ASX SMALL CAP LEADERS
Here are the best performing ASX small cap stocks:
Swipe or scroll to reveal full table. Click headings to sort:
Code Name Price % Change Volume Market Cap AMD Arrow Minerals 0.002 100% 4,926,059 $12,689,365 DOU Douugh Limited 0.005 67% 29,968,882 $3,246,207 BP8 Bph Global Ltd 0.003 50% 216,667 $793,283 IVX Invion Ltd 0.003 50% 10,583,988 $13,533,183 WEL Winchester Energy 0.002 50% 2,375,000 $1,363,019 CAN Cann Group Ltd 0.063 40% 3,381,389 $21,089,992 RIL Redivium Limited 0.007 40% 13,293,101 $13,734,274 DGR DGR Global Ltd 0.018 38% 4,472,068 $13,568,015 4DX 4Dmedical Limited 0.605 36% 7,260,845 $182,686,368 ATH Alterity Therap Ltd 0.004 33% 131,237 $15,961,008 NTM Nt Minerals Limited 0.004 33% 3,501,057 $3,052,209 OVT Ovanti Limited 0.004 33% 13,392,722 $4,669,045 RLG Roolife Group Ltd 0.004 33% 200,978 $3,507,439 VEN Vintage Energy 0.009 29% 1,142,158 $11,686,719 FBM Future Battery 0.023 28% 983,831 $11,976,407 NYR Nyrada Inc. 0.073 26% 1,822,992 $10,568,104 88E 88 Energy Ltd 0.003 25% 892,265 $57,867,624 CYQ Cycliq Group Ltd 0.005 25% 1,956,082 $1,782,067 TEG Triangle Energy Ltd 0.005 25% 12,604,156 $8,320,536 RTR Rumble Res Limited 0.047 24% 4,743,967 $28,744,631 NC6 Nanollose Limited 0.021 24% 30,000 $2,924,108 G50 G50Corp Ltd 0.160 23% 436,160 $15,718,300 NSM Northstaw 0.015 22% 63,157 $1,714,178
Yesterday’s Small Cap Winners included:
Douugh (ASX:DOU) was charging hard on news that it has signed a binding agreement to acquire US B2B fintech services platform R-DBX, in a deal that the company says will provide it with a stable positive income stream which in 2023 generated $1.1 million. Douugh has also secured $1 million in working capital via a loan from US-based Relentless Fintech Partners.
4D Medical (ASX:4DX) was up on news that it has signed a comprehensive distribution agreement with Philips, to help the company establish a transformative commercialisation pathway in the United States. Under the terms of the deal, Philips will have exclusive distribution rights to the 4DMedical suite of products with US government customers and non-exclusive rights with all other US customers.
Black Canyon (ASX:BCA) has been boosted by news that drilling has intersected high grade manganese at the W2 prospect at Wandanya, 80km south of the Woodie Woodie Mine in WA. The company says that Portable XRF (pXRF) analysis indicates grade ranges of between 15% to 55% Mn, but – arguably more importantly – the geology of the find “expands the scope to explore for additional high-grade mineralisation along strike where the company has mapped 1.75km of intermittent high grade outcropping manganese”.
Nyrada (ASX:NYR), a drug development company specialising in novel small molecule therapeutics, was climbing on news of the successful completion of a dog toxicology study for its lead candidate, NYR-BI03. The study provided continuing data to support safety and tolerability of the drug, and Nyrada says it is on track to commence first in-human Phase I clinical trial for NYR-BI03 in late CY2024.
Cobalt Blue (ASX:COB) was up on yesterday’s annual report. After booking a $30m impairment to the value of its assets earlier this year and facing oversupply in the cobalt market, COB had a pretty severe drop in share price of 67% in the last year.
An annual report released yesterday has started to lift spirits – and the stock price again – after stating concentrated commitments to its corporate governance and making significant strides in its operations.
This includes the initiation of the Kwinana Cobalt Refinery Study and the commencement of engineering work by Tetra-Tech, while also partnering with Iwatani Corp for potential collaboration on the refinery and its Broken Hill project.
Nothing brewing lately with Loyal Lithium (ASX:LLI) and the last announcement to the market was about partnering with McGill University to access a C$1m research grant to advance its lithium projects in Canada.
It’s got a field program underway at its flagship Trieste project in Quebec’s prolific James Bay lithium district where 10 geo’s are are conducting field prospecting and are due to wrap up the program today. They’ve been concentrating on five resistivity trends across an extensive 22km stretch that align with all six known spodumene-bearing pegmatite dyke outcrops within the project area that showed up to 2.2% Li2O near surface.
Polymetals Resources (ASX:POL) continues to skyrocket after receiving an upgraded ~$30m funding in a loan facility and offtake agreement with long term partner UK-based commodities trader Ocean Partners for its Endeavour base metals mine in mid-September.
The mine developer remains on track to restart Endeavour which comes in with a pre-tax NPV8% of $414m, IRR of a whopping 345% and free cash flow of $609m over the 10-year mine plan with an average annual EBITDA of $89m over the first five years.
YESTERDAY’S ASX SMALL CAP LAGGARDS
Here are the worst performing ASX small cap stocks:
Swipe or scroll to reveal full table. Click headings to sort:
Code Name Price % Change Volume Market Cap SGR The Star Ent Grp 0.255 -43% 230,852,832 $1,290,906,395 1TT Thrive Tribe Tech 0.001 -33% 15,000,000 $917,432 VML Vital Metals Limited 0.002 -33% 917,025 $17,685,201 AAU Antilles Gold Ltd 0.003 -25% 1,645,619 $7,422,971 CTO Citigold Corp Ltd 0.003 -25% 443,395 $12,000,000 MEL Metgasco Ltd 0.003 -25% 761,940 $5,790,347 RNE Renu Energy Ltd 0.002 -25% 1,979,250 $1,608,268 YAR Yari Minerals Ltd 0.003 -25% 300,000 $1,929,431 MPP Metro Perf.Glass Ltd 0.066 -22% 43,181 $15,757,137 BYH Bryah Resources Ltd 0.004 -20% 540,000 $2,516,434 ECT Env Clean Tech Ltd. 0.002 -20% 2,168 $7,929,526 SFG Seafarms Group Ltd 0.002 -20% 10,000 $12,091,498 TYX Tyranna Res Ltd 0.004 -20% 10,010 $16,439,627 KPO Kalina Power Limited 0.013 -19% 12,772,416 $39,782,304 CUL Cullen Resources 0.005 -17% 98,254 $4,160,411 IBG Ironbark Zinc Ltd 0.003 -17% 42,850 $5,500,943 STM Sunstone Metals Ltd 0.005 -17% 344,966 $25,955,422 CXU Cauldron Energy Ltd 0.021 -16% 3,400,549 $30,925,766 1AI Algorae Pharma 0.006 -14% 6,659,307 $11,811,763 JRV Jervois Global Ltd 0.012 -14% 10,132,155 $37,838,693 BNL Blue Star Helium Ltd 0.004 -13% 5,280,068 $9,724,426 BAS Bass Oil Ltd 0.071 -11% 2,069,057 $23,234,525
TRADING HALTS
A2 Milk (ASX:A2M) – to respond to ASX’s price query received this morning and to inform the market regarding a potential acquisition by A2M.
Estrella Resources (ASX:ESR) – No reason given by the ASX for the halt being called.
TMK Energy (ASX:TMK) – to allow TMK to manage its continuous disclosure obligations whilst it undertakes a capital raising.
At Stockhead, we tell it like it is. This article does not constitute financial product advice. You should consider obtaining independent advice before making any financial decisions.
Keywords:
Synonyms:
This article does not constitute financial product advice. You should consider obtaining independent advice before making any financial decisions.
The post Rise and Shine: Everything you need to know before the ASX opens appeared first on Stockhead.
